Incidence and development of zygotes exhibiting abnormal pronuclear disposition after identification of two pronuclei at the fertilization check
|
|
- Melvin McDowell
- 5 years ago
- Views:
Transcription
1 Incidence and development of zygotes exhibiting abnormal pronuclear disposition after identification of two pronuclei at the fertilization check David E. Reichman, M.D., Katharine V. Jackson, B.A., and Catherine Racowsky, Ph.D. Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women s Hospital, Boston, Massachusetts Objective: To determine the incidence, developmental potential, and clinical implications of embryos having one pronucleus (1PN) or three pronuclei (3PN) at early cleavage, despite exhibiting 2PN at the fertilization check. Design: Retrospective cohort study. Setting: Hospital-based academic medical center. Patient(s): All IVF cycles from January 2006 through May 2008 having 2PN zygotes that subsequently transitioned to 1PN or 3PN before cleavage, matched to cycles having 2PN zygotes progressing to cleavage without intervening abnormal pronuclear disposition. Intervention(s): Standard IVF protocol. Main Outcome Measure(s): Incidence, day 3 development, and implantation rates of 2PN zygotes transitioning to 1PN and 3PN states before cleavage, compared with normal embryos. Result(s): The incidences of 1PN and 3PN zygotes were 2.9% and 0.4%, respectively. Both types of abnormal zygote showed slower day 3 cleavage, although only the 1PNs exhibited higher fragmentation and asymmetry compared with controls. The 1PN zygotes had a 6.4% implantation rate and viable pregnancy rate of 1.3%. Of the nine 3PN zygotes transferred, none implanted. Conclusion(s): Two-pronuclear zygotes transitioning through 1PN or 3PN states tend to develop into poorer-quality embryos than 2PN control zygotes. Patients should be counseled regarding the very low likelihood of viable pregnancy after transfer of these abnormally developing zygotes. (Fertil Steril Ò 2010;94: Ó2010 by American Society for Reproductive Medicine.) Key Words: Unipronuclear, 1PN, tripronuclear, 3PN, early cleavage, IVF, ICSI, zygote Several studies have investigated the incidence, origin, development, and chromosomal composition of abnormal pronucleate zygotes (1 3). Single-pronucleate (1PN) zygotes are thought to be secondary to either parthenogenetic activation of the oocyte or abnormal syngamy of pronuclei, whereas tripronucleate (3PN) zygotes result from either dispermy or failure of extrusion of the second polar body. Although such embryos are usually discarded in IVF programs, healthy children have been born after transfer of 1PN embryos (4). It has become the practice of several centers to transfer such embryos in the absence of suitable alternatives. Studies, however, have focused on zygotes which, at hours after insemination, exhibited abnormal pronuclear number without ever being identified as having a normal two-pronucleate (2PN) state. In our experience, we have occasionally noted zygotes which exhibited evidence of normal fertilization with two pronuclei and later went on to display one pronucleus or three pronuclei when checking for early cleavage (24 27 hours after insemination). We hypothesized that such zygotes should be classified as abnormal Received February 16, 2009; revised and accepted April 8, 2009; published online May 23, D.E.R. has nothing to disclose. K.V.J. has nothing to disclose. C.R. has nothing to disclose. Reprint requests: Catherine Racowsky, Ph.D., Brigham & Women s Hospital, 75 Francis Street, ASB 1þ3, Rm 08, Boston, MA (FAX: ; cracowsky@partners.org). and would have poorer developmental potential and implantation rates than zygotes with two pronuclei. Upon our review of the existing literature, we could find only one study mentioning this phenomenon in a single fertilized oocyte (5) and no studies that examined the incidence, developmental fate, or suitability for transfer of these zygotes. Therefore, the purpose of the present study was to discover the incidence of these abnormally developing zygotes in our standard IVF population, to track their development based on cell number, fragmentation, and asymmetry on day 3, and to determine their suitability for transfer. MATERIALS AND METHODS This study was approved by the Partners Healthcare Institutional Review Board for chart review. Cycle Inclusion Criteria The index cycles identified for this study were culled after review of all IVF cycles (either standard insemination or intracytoplasmic sperm injection [ICSI]) performed in our program from January 2006 through May 2008 in which the embryos were evaluated for early cleavage (23.7 to 26.9 hours after insemination, mean time 25.1 hours) and for which development was followed in culture to day 3 (n ¼ 2,859 cycles) /$36.00 Fertility and Sterility â Vol. 94, No. 3, August doi: /j.fertnstert Copyright ª2010 American Society for Reproductive Medicine, Published by Elsevier Inc.
2 Clinical Protocols The patients typically had normal clomiphene citrate challenge testing (generally FSH levels <10 miu/ml) and underwent controlled ovarian stimulation with luteal down-regulation using leuprolide acetate (Lupron; TAP Pharmaceuticals, Lake Forest, IL). Leuprolide acetate was begun either 1 week after urinary LH surge or the day after midluteal P determination, and was continued until at least day 2 of menses. Baseline ultrasonography and blood testing were performed to document no ovarian cysts >3cm,E 2 <50 pg/ml, and P <1.5 ng/ml. Alternatively, in patients with histories of poor gonadotropin response or high levels of FSH (R10 miu/ml), poor responder protocols were implemented. Although these protocols varied, such protocols were typically either microdose lupron with 0.05 mg SC leuprolide acetate twice daily starting cycle day 1 after an oral contraceptive (OC) lead-in with baseline ultrasound testing performed on day 2, or a GnRH antagonist (GnRH-a) protocol using OC pills for 3 weeks with baseline ultrasound testing cycle day 2 and GnRH-a starting at a dose of 0.25 mg/day beginning stimulation day 6. When baseline criteria were met, gonadotropin therapy (either Gonal-F [Serono Laboratories, Rockland, MA] or Follistim [Organon, Roseland, NJ]) with or without hmg (Humegon [Organon], Pergonal, or Repronex [Ferring Pharmaceuticals, Suffern, NY]) was begun. Stimulation was accomplished using either a single dose or divided daily doses of between 2 and 8 ampules/day, depending on patient age and anticipated response. Monitoring of follicles was achieved using ultrasound. Serum E 2 levels were measured, in general, on stimulation day 6 and then every 1 3 days as indicated. A 10,000 IU dose of hcg (Profasi; Serono) was administered IM when the two lead follicles had a mean diameter of >16.5 mm and the E 2 concentration was >500 pg/ml. Retrieval was performed transvaginally 36 hours after hcg administration in the standard fashion using either IV or regional anesthesia. One day after oocyte retrieval, luteal P supplementation was begun using one of three regimens: 1) daily IM P (50 mg); 2) daily 8% P vaginal gel (Crinone; Wyeth-Ayerst, Madison, NJ); or 3) twice daily vaginal P suppositories ( mg). Embryo transfer was performed with a Wallace catheter (Marlow/Cooper Surgical, Shelton, CT). For difficult transfers, a Marrs no. 4 or Marrs no. 5 embryo transfer catheter (Cook Ob/Gyn, Spencer, IN) was occasionally used. Laboratory Protocols All gametes and embryos were maintained at 37 C in a humidified atmosphere of 5% CO 2 in air. Within 4 6 hours of retrieval, oocytes were inseminated in groups of 3 5 in 1 ml Ham F10 medium supplemented with 5% human serum albumin (Invitro Care, Frederick, MD) or were fertilized (within 3 5 hours after retrieval) via ICSI. Zygotes having 2PN at the fertilization check hours after insemination or ICSI were cultured individually in 25 ml of growth medium (G1.2, G1.3 [Scandinavian IVF Science/Vitrolife, Gothenburg, Sweden], or Life Global [IVF Online, Toronto, Canada]) overlaid with 8 ml oil in Falcon 1007 culture dishes (Becton Dickinson Labware, Franklin Lakes, NJ). Early cleavage check was carried out approximately hours after insemination to assist in identifying those embryos with maximal implantation potential (6 8). On day 3, the morphology of each embryo was assessed using standard criteria, with fragmentation and asymmetry being graded with numerical scores (9). Fragmentation scores of 0 through 4 were awarded to each embryo, where each score correlated to 0, 1% 9%, 10% 25%, 26% 50%, or >50% fragmentation, respectively. Blastomere asymmetry was graded using a numerical score of 1 through 3 according to uniformity in size and shape, where a score of 1 represented perfect symmetry, 2 moderate asymmetry, and 3 severe asymmetry. A team of six to eight embryologists, who participate in proficiency testing to ensure consistency in grading, performed the embryo assessments in our lab. Embryos with the lowest percentage of fragmentation, lowest asymmetry, and optimal number of cells were selected for transfer. Preference was given to eight-cell embryos when available, other characteristics being equal. Number of embryos transfered was determined according to number and quality of available embryos, patient age, and prior clinical history. Index Zygotes All 2PN zygotes at the fertilization check (n ¼ 23,293) were screened to identify those with one pronucleus or three pronuclei at early cleavage. Control Zygotes Two types of control groups of zygotes were assessed for each of the 1PN and 3PN datasets to compare embryo quality, implantation rates, and pregnancy rates with each type of index zygote: 1) internal control groups, composed of those 2PN zygotes from the same cycles as either the 1PN or 3PN zygotes but not exhibiting abnormal pronuclear number at early cleavage check; and 2) external matched-pair control groups, composed of zygotes from cycles performed during the same time period but with no 1PN or 3PN zygotes. These external control groups were obtained by matching each cycle having a 1PN or 3PN zygote with a control cycle for patient age, date of embryo retrieval, number of eggs retrieved, and number of embryos transferred. For accurate comparison, only control zygotes exhibiting 2PN or 0PN (rather than two or more cells) at early cleavage were selected for analysis. By creating this matched external control group we hoped to eliminate a source of bias, given the possibility that patients who produce 1PN or 3PN zygotes might not be representative of a normal IVF population. Outcome Variables Assessed Index zygotes were compared with zygotes in the internal and external control groups for distributions according to cell 966 Reichman et al. Abnormal pronuclei number late on day 1 Vol. 94, No. 3, August 2010
3 TABLE 1 Demographic comparison: index population (1PN) versus matched controls. 1PN Control No. cycles Age Attempt no Day 3 FSH (miu/ml) No. ampules Peak E 2 (pg/ml) 2, , No. eggs No. MII % 2PN/MII No. good-quality a * embryos No. embryos frozen y No. embryos transfered Note: Values represent mean SD. 1PN ¼ single pronucleus; MII ¼ metaphase II. a R8 cells with <10% fragmentation on day 3. * P<.004. y P<.02. number, fragmentation and asymmetry scores on day 3. In addition, implantation rates and pregnancy rates were compared for those zygotes with known developmental fate. Implantation rate was defined as the number of sacs detected by ultrasound at 5 6 weeks out of the total number of embryos transfered. Viable implantation rate was defined as the number of viable fetuses detected by ultrasound at 8 weeks out of the total number of embryos transferred. Pregnancy rate was defined as the number of transfers resulting in at least one viable fetus (by ultrasound to at least 8 weeks) out of all transfers performed. Statistical Analysis Differences between the index populations and matched-pair populations were determined using the Mann-Whitney U test. The data were analyzed using chi-squared with Fisher exact test, where P<.05 was considered to be statistically significant. RESULTS 1PN Zygotes Incidence and cycle demographics Of the 23,293 2PN zygotes evaluated at early cleavage, 671 (2.9%) exhibited 1PN. These 671 1PN zygotes arose from 445 patients and 512 cycles. The demographics of the cycles, along with those of the matched control group, are shown in Table 1. Comparison of the 1PN zygote population to the zygotes in the matched control cycles revealed significant differences only for the number of good-quality embryos (R8-cell with <10% fragmentation; P<.004]), and in number of embryos frozen (P<.02). No statistical significance among the index population was found between conventional IVF and ICSI in terms of number of 1PN zygotes obtained. Day 3 development of 1PN zygotes Figure 1 depicts the distribution of embryos according to cell number on day 3 for the index population compared with that for the internal and external control groups. Other than a higher number of 14-cell embryos in the internal control group, no statistical significance was uncovered regarding cell number between the two control groups. Therefore, for simplicity of presentation, statistical comparisons for cell number were made between the 1PN embryos and only those in the internal controls. The 1PN embryos showed a significant delay in cleavage, as reflected by significant increases in the percentage of embryos having 1 4 cells, and significant decreases in those with 6 8 or 10 cells (Fig. 1). The quality of these embryos was further assessed by comparing fragmentation and asymmetry scores with those of the two control groups. Significantly fewer 1PN embryos exhibited <10% fragmentation compared with either control group (42.1% for index vs. 54.9% for internal control [P<.0007] and vs. 54.2% for external control [P<.002]), with a corresponding significant increase in the proportion having 10% 25% fragmentation (42.1% for index vs. 34.0% for internal control [P<.0245] and 32.5% for external control [P<.007]). A trend toward increased asymmetry was observed for 1PN embryos, although this did not reach statistical significance. Developmental competency of 1PN zygotes In total, 98 of the 671 index embryos were transferred. Determining a precise implantation rate was obscured, given that 20 of the affected embryos were transfered along with unaffected embryos in cycles resulting in pregnancy but with less than 100% implantation. However, for 78 of the affected transferred embryos, developmental fate was certain. The implantation rate was 6.4% (5 sacs out of 78 embryos transfered). The viable implantation rate was 1.3% (1 viable fetus at 8 weeks out of 78 embryos transfered). Of the 76 transfers involving these 78 embryos of known developmental fate, one resulted in a viable pregnancy (1.3% pregnancy rate). In comparison, for the matched control group, the viable implantation rate was 20.7% (271 fetuses out of 1,309 embryos transfered) and the pregnancy rate was 40.4% (207 out of 512 transfers with at least one viable fetus). Of note, the one pregnancy that resulted from the transfer of a single affected embryo culminated in the delivery at 39 weeks of a healthy female weighing 3,316 g. 3PN Zygotes Incidence and cycle demographics Of the 23,293 2PN zygotes evaluated at early cleavage, 99 (0.42%) exhibited 3PN. These 3PN zygotes arose from 89 patients and 94 cycles. The demographics of the cycles, along with those of the matched control group, are shown in Table 2. Comparison of 3PN embryos to those in the matched control cycles revealed significant differences only for number of embryos Fertility and Sterility â 967
4 FIGURE 1 Number of cells on day 3 of zygotes with aberrant single-pronucleate (1PN) state at early cleavage compared with control groups. frozen (P<.01). No statistical significance among the index population was found between conventional IVF and ICSI regarding number of 3PN zygotes obtained. Day 3 development of 3PN zygotes Figure 2 depicts the distribution of embryos according to cell number on day 3 for the index population compared with those for the internal and external control groups. Again, our two control groups revealed consistent patterns for embryo cell number; other than a higher number of 11-cell embryos in the matched pair group, no statistical significance was found regarding cell number between the two groups. The 3PN embryos revealed a marked trend toward an increased percentage of embryos having %4 cells, with a corresponding significant decrease in those exhibiting 8 cells (P¼.0001). The quality of these embryos was further assessed by comparing fragmentation and asymmetry scores to those of the two control groups. However, no statistically significant differences were detected between index embryos and control groups regarding fragmentation or asymmetry, and no trend was discernible (data not shown). Developmental competency of 3PN zygotes In total, 9 of the 99 3PN embryos were transferred. Unlike their 1PN counterparts, none of the 3PN embryos implanted. In comparison, the viable implantation rate and pregnancy rate for the corresponding matched control group were 18.4% (45 fetuses out of 244 embryos transfered) and 40.4% (38 pregnancies with at least 1 viable fetus out of 94 transfers), respectively. DISCUSSION In this study, we set out to assess the development potential and clinical implications of embryos with one pronucleus or three pronuclei at early cleavage check despite their having exhibited two pronuclei at the time of fertilization. We discovered that these relatively rare phenomena resulted in embryos that exhibited diminished embryo quality for both 1PN and 3PN zygotes, as well as markedly decreased implantation and pregnancy rates compared with our control assisted reproductive technologies population. The process of pronuclear fusion has been well described in the literature. Syngamy is characterized by close association of maternal and paternal pronuclei with occasional occurrence of interdigitation of the opposing nuclear membranes (10). However, fusion of the two pronuclei occurs only after breakdown of the nuclear membranes (11). The 2PN zygote thereby progresses to a one-cell embryo lacking any overt evidence of pronuclei before proceeding through interphase of the first mitotic division, ultimately to undergo cytokinesis and form the two-cell embryo. Although embryos with abnormal pronuclear number have been described, such embryos typically represent events of 968 Reichman et al. Abnormal pronuclei number late on day 1 Vol. 94, No. 3, August 2010
5 TABLE 2 Demographic comparison: index population (3PN) versus matched controls. 3PN Control No. cycles Age Attempt no Day 3 FSH (miu/ml) No. ampules Peak E 2 (pg/ml) 2,260 1,057 2, No. eggs No. MII %2PN/MII No. good-quality a embryos No. embryos frozen * No. embryos transfered Note: Values represent mean SD. 3PN ¼ three pronuclei; MII ¼ metaphase II. a R8 cells with <10% fragmentation on day 3. * P<.01. abnormal fertilization, whether via parthenogenetic activation of the oocyte, dispermy, or failure of extrusion of the second polar body (1, 12). These rare embryos are typically discarded at the time of the fertilization check, given their abnormal chromosomal makeup and dismal prospects for reproductive success. Rarely, however, embryos are noted to appear normally fertilized, exhibiting 2PN status, but subsequently deviate from normal development. To our knowledge, only one article has previously addressed the type of embryos studied in the present paper, without a subsequent examination of their developmental integrity or role in assisted reproduction (5). Checking zygotes late on day 1 for early cleavage has been reported to improve embryo selection by identifying those embryos with the greatest implantation potential (6 8). Doing so, however, has revealed zygotes such as those described in this paper, whose development deviates from the norm. Although such embryos were noted to occur relatively rarely in our lab, identifying their developmental potential is useful, especially when patients have few high-quality embryos for transfer and the embryos of the seemingly highest quality have transitioned through abnormal pronuclear milestones. The question arises as to whether, in the absence of high-quality normal embryos, an embryo which at early cleavage check exhibited an abnormal number of pronuclei but subsequently developed into a symmetric, unfragmented eight-cell embryo should be transferred preferentially over a traditional embryo with less optimal parameters. The findings we present here show that the implantation potential of such deviant embryos is <2%, indicating that transfer of these embryos should be avoided when possible. The etiology of these embryos remains unclear. It would be informative to karyotype such embryos to identify whether their unusual development is associated with aneuploidy, as has been done with abnormally pronucleated zygotes of the more traditional variety (i.e., having not first achieved a complement of two pronuclei [4, 13]). Although dispermy, parthenogenetic oocyte activation, or asynchronous dissolution of the pronuclear membrane may, respectively, explain the appearance of 3PN or 1PN zygotes identified at the fertilization check, an alternative explanation must be found for the appearance of these pronuclear stages after normal 2PN development. It is of interest that both types of abnormal zygotes occurred in cycles with unusually high yields of oocytes (mean SD: and , respectively; Tables 1 and 2). In our program, we retrieve ten oocytes on average. Although it was not the focus of the present study, this finding raises the question whether cycles with high oocyte yield, or patients predisposed to higher oocyte yield, may be especially susceptible to forming such abnormal zygotes. In reviewing the infertility diagnoses for our 1PN and 3PN groups, we discovered that 11.7 % and 9.6% of patients, respectively, carried the diagnosis of PCOS or anovulatory dysfunction, a diagnosis correlated with robust ovarian response during superovulation. Perhaps further studies could elucidate whether this association bears any causal relationship. Tripronucleate embryos occurred more rarely and displayed poorer developmental fate regarding cell number on day 3 of culture. Single-pronucleate embryos, on the other hand, more closely followed the development of normal embryos, while still resulting in a statistically significant decrease in the number of highest-quality embryos. This study is not without limitations. Although the scoring of embryos was performed by well trained embryologists in a - major academic center, this grading is subject to human error. However, given the abnormal cleavage rates exhibited by both the 1PN and 3PN populations, it is likely that PN scoring was accurate in at least the majority of cases. This study takes a retrospective approach; however, given the rare nature of these embryos and an inability to predict their occurrence, performing a prospective study would be both resource and time intensive. It is our hope that the present findings may aid centers of reproductive medicine in offering the highest chances of success to IVF patients. By elucidating the developmental fate and reproductive potential of the abnormal zygotes in this study, we hope to assist embryologists in selecting those embryos with the highest implantation potential while excluding, as in this study, those embryos whose deviation from the norm results in suboptimal rates of successful pregnancy. CONCLUSION In this study, we examined the incidence, developmental fate, and implantation rate of zygotes noted to have two pronuclei at the fertilization check but to have transitioned to an abnormal PN number at early cleavage check late on day 1. The Fertility and Sterility â 969
6 FIGURE 2 Number of cells on day 3 of zygotes with aberrant tripronucleate (3PN) state at early cleavage compared with control groups. present results indicate that such 1PN and 3PN zygotes at early cleavage are both relatively rare, with 1PN zygotes being the more common of the two. Such embryos were noted to have poorer overall development characteristics compared with control groups as well as a marked decrease in both implantation potential and pregnancy rate. Patients should therefore be counseled regarding the very low likelihood of viable pregnancy after transfer of these abnormally developing zygotes in the event that no other suitable embryos are available for transfer. Further studies are needed to elucidate the origin of abnormal pronuclear stages after normal fertilization. Acknowledgment: We thank all of the embryologists at Brigham and Women s Hospital for their expertise in embryo grading, and their tireless commitment to maintaining the highest standards of care to our patients. REFERENCES 1. Balakier H, Squire J, Casper RF. Characterization of abnormal one pronuclear human oocytes by morphology, cytogenetics and in-situ hybridization. Hum Reprod 1993;8: Balakier H. Tripronuclear human zygotes: the first cell cycle and subsequent development. Hum Reprod 1993;8: Munne S, Tang Y, Grifo J, Cohen J. Origin of single pronucleated human zygotes. J Assist Reprod Genet 1993;10: Staessen C, Janssenswillen C, Devroey P, Van Steirteghem AC. Cytogenetic and morphological observations of single pronucleated human oocytes after in-vitro fertilization. Hum Reprod 1993;8: Nagy ZP, Liu J, Joris H, Devroey P, Van Steirteghem A. Time-course of oocyte activation, pronucleus formation and cleavage in human oocytes fertilized by intracytoplasmic sperm injection. Hum Reprod 1994;9: Shoukir Y, Campana A, Farley T, Sakkas D. Early cleavage of in-vitro fertilized human embryos to the 2-cell stage: a novel indicator of embryo quality and viability. Hum Reprod 1997;12: Sakkas D, Shoukir Y, Chardonnens D, Bianchi PG, Campana A. Early cleavage of human embryos to the two-cell stage after intracytoplasmic sperm injection as an indicator of embryo viability. Hum Reprod 1998;13: Neuber E, Rinaudo P, Trimarchi JR, Sakkas D. Sequential assessment of individually cultured human embryos as an indicator of subsequent good quality blastocyst development. Hum Reprod 2003;18: Racowsky C, Combelles CM, Nureddin A, Pan Y, Finn A, Miles L, et al. Day 3 and day 5 morphological predictors of embryo viability. Reprod Biomed Online 2003;6: Xu KP, Greve T. A detailed analysis of early events during in-vitro fertilization of bovine follicular oocytes. J Reprod Fertil 1988;82: Levron J, Munne S, Willadsen S, Rosenwaks Z, Cohen J. Male and female genomes associated in a single pronucleus in human zygotes. Biol Reprod 1995;52: Grossman M, Calafell JM, Brandy N, Vanrell JA, Rubio C, Pellicer A, et al. Origin of tripronucleate zygotes after intracytoplasmic sperm injection. Hum Reprod 1997;12: Kola I, Trounson A, Dawson G, Rogers P. Tripronuclear human oocytes: altered cleavage patterns and subsequent karyotypic analysis of embryos. Biol Reprod 1987;37: Reichman et al. Abnormal pronuclei number late on day 1 Vol. 94, No. 3, August 2010
Benefit of intracytoplasmic sperm injection in patients with a high incidence of triploidy in a prior in vitro fertilization cycle
IN VITRO FERTILIZATION Benefit of intracytoplasmic sperm injection in patients with a high incidence of triploidy in a prior in vitro fertilization cycle Sunny H. Jun, M.D., a Thomas O Leary, B.S., b Katharine
More informationEarly compaction on day 3 may be associated with increased implantation potential
Early compaction on day 3 may be associated with increased implantation potential Christine C. Skiadas, M.D., Katharine V. Jackson, B.S., and Catherine Racowsky, Ph.D. Department of Obstetrics, Gynecology
More informationPredictive value of embryo grading for embryos with known outcomes
Predictive value of embryo grading for embryos with known outcomes Vanessa N. Weitzman, M.D., Jennifer Schnee-Riesz, M.D., Claudio Benadiva, M.D., John Nulsen, M.D., Linda Siano, M.S., and Donald Maier,
More informationThe number of eight-cell embryos is a key determinant for selecting day 3 or day 5 transfer
FERTILITY AND STERILITY VOL. 73, NO. 3, MARCH 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. The number of eight-cell
More informationVanessa N. Weitzman, M.D., Lawrence Engmann, M.D., Andrea DiLuigi, M.D., Donald Maier, M.D., John Nulsen, M.D., and Claudio Benadiva, M.D.
Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol
More informationEffects of triploidy after intracytoplasmic sperm injection on in vitro fertilization cycle outcome
Effects of triploidy after intracytoplasmic sperm injection on in vitro fertilization cycle outcome Molina B. Dayal, M.D., M.P.H., Paul R. Gindoff, M.D., Abbaa Sarhan, M.D., Anil Dubey, Ph.D., Douglas
More informationSubmitted April 2, 2003; accepted June 5, KEY WORDS: Fertility; fertilization; oocyte; reproductive techniques. INTRODUCTION
( C 2003) Assisted Reproduction Estimation of Second Polar Body Retention Rate After Conventional Insemination and Intracytoplasmic Sperm Injection: In Vitro Observations From more than 5000 Human Oocytes
More informationElena H. Yanushpolsky, M.D., a Shelley Hurwitz, Ph.D., b Eugene Tikh, B.S., c and Catherine Racowsky, Ph.D. a
FERTILITY AND STERILITY VOL. 80, NO. 1, JULY 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Predictive usefulness of cycle
More informationDuration of progesterone-in-oil support after in vitro fertilization and embryo transfer: a randomized, controlled trial
Duration of progesterone-in-oil support after in vitro fertilization and embryo transfer: a randomized, controlled trial Christine S. Goudge, M.D., Theodore C. Nagel, M.D., and Mark A. Damario, M.D. Division
More informationZygotes showing a single pronucleus
In vitro development and chromosome constitution of embryos derived from monopronucleated zygotes after intracytoplasmic sperm injection Sílvia Mateo, M.Sc., a Monica Parriego, M.Sc., a Montserrat Boada,
More informationH.Van de Velde 1, Z.P.Nagy, H.Joris, A.De Vos and A.C.Van Steirteghem
Human Reproduction vol.12 no.10 pp.2246 2250, 1997 Effects of different hyaluronidase concentrations and mechanical procedures for cumulus cell removal on the outcome of intracytoplasmic sperm injection
More informationExtended embryo culture in human assisted reproduction treatments
Human Reproduction Vol.16, No.5 pp. 902 908, 2001 Extended embryo culture in human assisted reproduction treatments M.T.Langley 1,3, D.M.Marek 1, D.K.Gardner 2, K.M.Doody 1 and K.J.Doody 1 1 Center for
More informationIVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW
IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW Jon Havelock, MD, FRCSC, FACOG Co-Director - PCRM Disclosure No conflict of interest in relation
More informationArticle Relationship between even early cleavage and day 2 embryo score and assessment of their predictive value for pregnancy
RBMOnline - Vol 14. No 3. 27 294-299 Reproductive BioMedicine Online; www.rbmonline.com/article/2585 on web 22 January 27 Article Relationship between even early cleavage and day 2 embryo score and assessment
More informationRole of embryo morphology in Intracytoplasmic Sperm Injection cycles for prediction of pregnancy
Iranian Journal of Reproductive Medicine Vol.5. No.1. pp:23-27, Winter 2007 Role of embryo morphology in Intracytoplasmic Sperm Injection cycles for prediction of pregnancy Mir Mehrdad Farsi, Ph.D., Ali
More informationINDICATIONS OF IVF/ICSI
PROCESS OF IVF/ICSI INDICATIONS OF IVF/ICSI IVF is most clearly indicated when infertility results from one or more causes having no other effective treatment; Tubal disease. In women with blocked fallopian
More informationOVULATION INDUCTION. Hsiang, Kaohsiung, Taiwan (FAX: ; adm.cgmh.org.tw).
OVULATION INDUCTION Significantly superior response in the right ovary compared with the left ovary after stimulation with follicle-stimulating hormone in a pituitary down-regulation regimen Kuo-Chung
More informationI. ART PROCEDURES. A. In Vitro Fertilization (IVF)
DFW Fertility Associates ASSISTED REPRODUCTIVE TECHNOLOGY (ART) Welcome to DFW Fertility Associates/ Presbyterian-Harris Methodist Hospital ARTS program. This document provides an overview of treatment
More informationBlastocyst culture and transfer increases the efficiency of oocyte donation
FERTILITY AND STERILITY VOL. 74, NO. 3, SEPTEMBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Blastocyst culture
More informationPreimplantation genetic diagnosis: polar body and embryo biopsy
Human Reproduction, Vol. 15, (Suppl. 4), pp. 69-75, 2000 Preimplantation genetic diagnosis: polar body and embryo biopsy Luca Gianaroli SISMER, Via Mazzini 12, 40138 Bologna, Italy Scientific Director
More informationA Tale of Three Hormones: hcg, Progesterone and AMH
A Tale of Three Hormones: hcg, Progesterone and AMH Download the Ferring AR ipad/iphone app from the Apple Store: http://bit.ly/1okk74m Interpreting Follicular Phase Progesterone Ernesto Bosch IVI Valencia,
More informationStudy on Several Factors Involved in IVF-ET of Human Beings
Study on Several Factors Involved in IVF-ET of Human Beings Lei X 1, Zhuoran W 1, Bin L 1, Huiming L 1, Hongxiu Z 1, Yajuan Z 1, Yingbo Q 1, Guixue Z 2 1 The First Clinical College of Harbin Medical University,
More informationInterpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used
Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used Ellenbogen A., M.D., Shalom-Paz E., M.D, Asalih N., M.D, Samara
More informationCorrelation between embryo morphology and development and chromosomal complement
Asian Pacific Journal of Reproduction 2014; 3(2): 85-89 85 Asian Pacific Journal of Reproduction Journal homepage: www.apjr.net Document heading doi: 10.1016/S2305-0500(14)60009-9 Correlation between embryo
More informationCycle Plan Page1 CYCLE PLAN TYPE CYCLE TYPE: Initial Plan Updated Plan Management Team Review Monitoring Review
Cycle Plan Page1 CYCLE PLAN TYPE Initial Plan Updated Plan Management Team Review Monitoring Review CYCLE TYPE: Undecided - diagnostic testing only Natural Cycle Coitus with IUI Ovulation Induction CC
More informationOriginal Effect of A Time-lapse Incubator (EmbryoScope ) on in vitro Culture of Human Embryos
J. Mamm. Ova Res. Vol. 31 (1), 40 44, 2014 40 Original Effect of A Time-lapse Incubator (EmbryoScope ) on in vitro Culture of Human Embryos Yamato Mizobe*, Toshiaki Akiyoshi, Shiho Minami, Kan Matsuo,
More informationArticles Does pronuclear morphology and/or early cleavage rate predict embryo implantation potential?
RBMOnline - Vol 2. No 1. 12 16 Reproductive BioMedicine Online webpaper 2000/039 on web 7/2/01 Articles Does pronuclear morphology and/or early cleavage rate predict embryo implantation potential? Dr Monalill
More informationHana Park, Chung-Hoon Kim, Eun-Young Kim, Jei-Won Moon, Sung-Hoon Kim, Hee-Dong Chae, Byung-Moon Kang
Original Article Obstet Gynecol Sci 2015;58(6):481-486 http://dx.doi.org/10.5468/ogs.2015.58.6.481 pissn 2287-8572 eissn 2287-8580 Effect of second-line surgery on in vitro fertilization outcome in infertile
More informationIn vitro maturation, fertilization, and development of human germinal vesicle oocytes collected from stimulated cycles
FERTILITY AND STERILITY VOL. 74, NO. 6, DECEMBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. In vitro maturation,
More informationSynchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome
Reproductive BioMedicine Online (2012) 24, 527 531 www.sciencedirect.com www.rbmonline.com ARTICLE Synchronization between embryo development and endometrium is a contributing factor for rescue ICSI outcome
More informationLuteal phase rescue after GnRHa triggering Progesterone and Estradiol
Luteal phase rescue after GnRHa triggering Progesterone and Estradiol L. Engmann University of Connecticut Disclaimer Fertility Speaker Bureau Merck Pharmaceuticals Introduction GnRH agonist is effective
More informationBlastocyst-stage embryo transfer in patients who failed to conceive in three or more day 2 3 embryo transfer cycles: a prospective, randomized study
FERTILITY AND STERILITY VOL. 81, NO. 3, MARCH 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Blastocyst-stage embryo transfer
More informationIncidence of Chromosomal Abnormalities from a Morphologically Normal Cohort of Embryos in Poor- Prognosis Patients
Incidence of Chromosomal Abnormalities from a Morphologically Normal Cohort of Embryos in Poor- Prognosis Patients M. C. MAGLI,1 L. GIANAROLI,1,3 S. MUNNE,2 and A. P. FERRARETTI1 Submitted: December 29,
More informationPossible factors affecting the development of oocytes in in-vitro maturation
Human Reproduction Vol. 15, (Suppl. 5) pp. 11-17, 2000 Possible factors affecting the development of oocytes in in-vitro maturation Anne Lis Mikkelsen 1 ' 2, Steven Smith 1 and Svend Lindenberg 1 ^he Fertility
More informationIN VITRO FERTILIZATION
FERTILITY AND STERILITY VOL. 72, NO. 5, NOVEMBER 1999 Copyright 1999 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. IN VITRO FERTILIZATION
More informationIs it the seed or the soil? Arthur Leader, MD, FRCSC
The Physiological Limits of Ovarian Stimulation Is it the seed or the soil? Arthur Leader, MD, FRCSC Objectives 1. To consider how ovarian stimulation protocols work in IVF 2. To review the key events
More informationThe serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins
Original Article Obstet Gynecol Sci 2018;61(2):242-246 https://doi.org/10.5468/ogs.2018.61.2.242 pissn 2287-8572 eissn 2287-8580 The serum estradiol/oocyte ratio in patients with breast cancer undergoing
More informationPatient selection criteria for blastocyst culture in IVF/ICSI treatment
J Assist Reprod Genet (2010) 27:555 560 DOI 10.1007/s10815-010-9457-9 ASSISTED REPRODUCTION Patient selection criteria for blastocyst culture in IVF/ICSI treatment M. Y. Thum & V. Wells & H. Abdalla Received:
More informationFertilization failures and abnormal fertilization after intracytoplasmic sperm injection
Fertilization failures and abnormal fertilization after intracytoplasmic sperm injection Sean P.Flaherty 1, Dianna Payne and Colin D.Matthews Reproductive Medicine Unit, Department of Obstetrics and Gynaecology,
More informationOptimal ICSI timing after the first polar body extrusion in in vitro matured human oocytes
Human Reproduction Vol.22, No.7 pp. 1991 1995, 2007 Advance Access publication on May 18, 2007 doi:10.1093/humrep/dem124 Optimal ICSI timing after the first polar body extrusion in in vitro matured human
More informationArticle Outcome of 1114 ICSI and embryo transfer cycles of women 40 years of age and over
RBMOnline - Vol 13. No 4. 2006 516-522 Reproductive BioMedicine Online; www.rbmonline.com/article/2391 on web 15 August 2006 Article Outcome of 1114 ICSI and embryo transfer cycles of women 40 years of
More informationComparison of embryo development in sibling oocytes cultured in two different sequential media
Middle East Fertility Society Journal Vol. 9, No. 2, 2004 Copyright Middle East Fertility Society Comparison of embryo development in sibling oocytes cultured in two different sequential media Necati Findikli,
More informationPuerto Rico Fertility Center
Puerto Rico Fertility Center General Information of the In-Vitro Fertilization Program Dr. Pedro J. Beauchamp First test-tube baby IN PUERTO RICO Dr. Pedro Beauchamp with Adlin Román in his arms. Paseo
More informationInfluence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser
Influence ovarian stimulation on oocyte and embryo quality Prof.Dr. Bart CJM Fauser How to balance too much vs too little? Lecture Outline Context ovarian stimulation Impact ovarian stimulation on oocyte
More informationIvf day 6 estradiol level
Ivf day 6 estradiol level Search It is also important to measure the estradiol on day 3. Day 2 is fine. The reason its day 3 is 15-20 years ago, the IVF medications were always started on day 3. Day 3
More informationSherman J.Silber 1,3, Zsolt Nagy 2, Paul Devroey 2, Michel Camus 2 and André C.Van Steirteghem 2
Human Reproduction vol.12 no.12 pp.2693 2700, 1997 The effect of female age and ovarian reserve on pregnancy rate in male infertility: treatment of azoospermia with sperm retrieval and intracytoplasmic
More informationChanges in measured endometrial thickness predict in vitro fertilization success
Changes in measured endometrial thickness predict in vitro fertilization success Grant D. E. McWilliams, D.O., a and John L. Frattarelli, M.D. b a Tripler Army Medical Center, Honolulu, Hawaii; and b Reproductive
More informationOocyte maturity and preimplantation development in relation to follicle diameter in gonadotropin-releasing hormone agonist or antagonist treatments
IN VITRO FERTILIZATION Oocyte maturity and preimplantation development in relation to follicle diameter in gonadotropin-releasing hormone agonist or antagonist treatments Daniela Nogueira, Ph.D., a Shevach
More informationDoes previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation treatment cycles?
J Assist Reprod Genet (26) 23:427 431 DOI 1.17/s1815-6-965-x ASSISTED REPRODUCTION Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation
More informationCopyright 1995 American Society for Reproductive Medicine
FERTILITY AND STERILITY Vol. 64, No.6, December 1995 Copyright 1995 American Society for Reproductive Medicine Printed on acid free paper in U. S. A. Prospective, auto-controlled study on reinsemination
More informationAssisted reproductive technology
Assisted reproductive technology FERTILITY AND STERILITY Copyright 1994 The American Fertility Society Vol. 62, No.4, October 1994 Printed on acid-free paper in U. S. A. Cryopreservation of supernumerary
More informationAssisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi
Assisted Reproduction By Dr. Afraa Mahjoob Al-Naddawi Learning Objectives: By the end of this lecture, you will be able to: 1) Define assisted reproductive techniques (ART). 2) List indications for various
More informationNeil Goodman, MD, FACE
Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects
More informationDoes a woman s educational attainment influence in vitro fertilization outcomes?
Does a woman s educational attainment influence in vitro fertilization outcomes? The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters.
More informationIn Vitro Fertilization What to expect
Patient Education In Vitro Fertilization What to expect This handout describes how to prepare for and what to expect when you have in vitro fertilization. It provides written information about this process,
More informationIn vitro fertilization outcome in the presence of severe male factor infertility*
FERTILITY AND STERILITY Vol. 63, No.5, May 1995 Copyright 1995 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. In vitro fertilization outcome in the presence of severe
More informationIn Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome
Original Article Effect of Laparoscopic Ovarian Drilling on Outcomes of In Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome Maryam Eftekhar, M.D. 1, Razieh Deghani Firoozabadi,
More informationComparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization
Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization Peter Kovacs, M.D., a Timea Kovats, M.D., a Artur Bernard,
More informationin vitro fertilization
FERTILITY AND STERILITY VOL 69, NO. 6, JUNE 1998 Copyright (#1998 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Elevated levels of basal
More informationThe effects of prior gravidity on the outcomes of ovum donor and own oocyte cycles
FERTILITY AND STERILITY Vol. 65, No.3, March 1996 Copyright t';, 1996 American Society for Reproductive Medicine Printed on acid-free paper in U. s. A. The effects of prior gravidity on the outcomes of
More informationA luteal estradiol protocol for anticipated poor-responder patients may improve delivery rates
A luteal estradiol protocol for anticipated poor-responder patients may improve delivery rates Micah J. Hill, D.O., a Grant D. E. McWilliams, D.O., b Kathleen A. Miller, B.S., c Richard T. Scott, Jr, M.D.,
More informationEffect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial
FULL PROJECT TITLE: Effect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial (STimulation Resulting in Embryonic Aneuploidy using Menopur (STREAM)
More information% Oocyte Donation Pregnancyes (days 3)
Ovulation induction in oocyte donors Roma- September 2007 Dr. José Remohí Dr. Carmen Rubio Dr. Amparo Mercader Dr. Pilar Alama Dr. Marco Melo Evolution of oocyte donation cycles 1500 1500 1000 58% 661
More informationAcupuncture Treatment For Infertile Women Undergoing Intracytoplasmic Sperm injection
Acupuncture Treatment For Infertile Women Undergoing Intracytoplasmic Sperm injection Sandra L. Emmons, MD Phillip Patton, MD Source: Medical Acupuncture, A Journal For Physicians By Physicians Spring
More informationProgesterone and clinical outcomes
Synchronization of Slowly Developing Embryos Restores Implantation Success Richard T. Scott, Jr, MD, HCLD Clinical and Scientific Director, Reproductive Medicine Associates of New Jersey Professor and
More informationREstradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization
REstradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? FTThe Journal of Reproductive
More informationWhat is the POSEIDON concept?
Improving Success in ART: how to define it and key strategies to get the best outcomes, Kiev, 21-09-2018 What is the POSEIDON concept? Alessandro Conforti Italy Objectives Unravel the definition of POR
More informationA prospective trial of blastocyst culture and transfer
Human Reproduction Vol.17, No.7 pp. 1846 1851, 2002 A prospective trial of blastocyst culture and transfer Takafumi Utsunomiya 1, Tae Naitou and Miyuki Nagaki St Luke Clinic, 5, Tsumori-Tomioka, Oita City,
More informationInfertility treatment
In the name of God Infertility treatment Treatment options The optimal treatment is one that provide an acceptable success rate, has minimal risk and is costeffective. The treatment options are: 1- Ovulation
More informationRole of total antioxidant capacity in the differential growth of human embryos in vitro
IN VITRO FERTILIZATION Role of total antioxidant capacity in the differential growth of human embryos in vitro Mohamed Bedaiwy, M.D., a,b,e Ashok Agarwal, Ph.D., a,b,c Tamer M. Said, M.D., a,c Jeffery
More informationRejuvenation of Gamete Cells; Past, Present and Future
Rejuvenation of Gamete Cells; Past, Present and Future Denny Sakkas PhD Scientific Director, Boston IVF Waltham, MA, USA Conflict of Interest I have no conflict of interest related to this presentation.
More informationPredictive factors of successful pregnancy after assisted reproductive technology in women aged 40 years and older
Reprod Med Biol (2009) 8:145 149 DOI 10.1007/s12522-009-0023-z ORIGINAL ARTICLE Predictive factors of successful pregnancy after assisted reproductive technology in women aged 40 years and older Akihisa
More informationUnderstanding eggs, sperm and embryos. Marta Jansa Perez Wolfson Fertility Centre
Understanding eggs, sperm and embryos Marta Jansa Perez Wolfson Fertility Centre What does embryology involve? Aims of the embryology laboratory Creation of a large number of embryos and supporting their
More informationWOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IVF WITH EMBRYO TRANSFER
*40639* 40639 WOMEN & INFANTS HOSPITAL Providence, RI 02905 CONSENT FOR IVF WITH EMBRYO TRANSFER I have requested treatment by the physicians and (Print Patient s name) staff of the Women & Infants Fertility
More informationFirst successful pregnancies following embryo selection using Time-lapse technology in Iran: Case report
Iran J Reprod Med Vol. 13. No. 4. pp: 237242, April 2015 Case report First successful pregnancies following embryo selection using Timelapse technology in Iran: Case report Azita Faramarzi Ph.D. candidate,
More informationTimur Giirgan, M.D.* Bulent Urman, M.D. Hakan Yarali, M.D. Hakan E. Duran, M.D.
FERTILITY AND STEFULI~ Vol. 68, No. 3, September 1997 Copyright 1997 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Published by Elsevier Science Inc. Follicle-stimulating
More informationFor these reasons we hypothesized that, because the ICSI procedure can be performed in a few minutes by experienced
Use of a medium buffered with N-hydroxyethylpiperazine-N-ethanesulfonate (HEPES) in intracytoplasmic sperm injection procedures is detrimental to the outcome of in vitro fertlization Francesco Morgia,
More informationIn Vitro Fertilization
Patient Education In Vitro Fertilization About the treatment This handout describes how to prepare for and what to expect when you have in vitro fertilization. It provides written information about this
More informationArticle Effect of gonadotrophin priming on in-vitro maturation of oocytes collected from women at risk of OHSS
RBMOnline - Vol 13. No 3. 2006 340 348 Reproductive BioMedicine Online; www.rbmonline.com/article/2328 on web 12 June 2006 Article Effect of gonadotrophin priming on in-vitro maturation of oocytes collected
More informationChromosomal Aneuploidy
The Many Advantages of Trophectoderm Biopsy Compared to Day 3 Biopsy for Pre- Implantation Genetic Screening (PGS) Mandy Katz-Jaffe, PhD Chromosomal Aneuploidy Trisomy 21 Fetus Aneuploidy is the most common
More informationAbstract. Introduction. Materials and methods. Patients and methods
RBMOnline - Vol 8. No 3. 344-348 Reproductive BioMedicine Online; www.rbmonline.com/article/1178 on web 20 January 2004 Article Cumulative live birth rates after transfer of cryopreserved ICSI embryos
More informationArticle Kinetic markers of human embryo quality using time-lapse recordings of IVF/ICSI-fertilized oocytes
RBMOnline - Vol 17 No 3. 2008 385-391 Reproductive BioMedicine Online; www.rbmonline.com/article/3327 on web 30 July 2008 Article Kinetic markers of human embryo quality using time-lapse recordings of
More informationIVF: PAST, PRESENT AND FUTURE
IVF: PAST, PRESENT AND FUTURE Mark Larman Chief Scientific Officer 1 HISTORY OF IVF IVF first achieved with rabbits in 1959 IVF with human gametes - pioneered by Robert Edwards and Patrick Steptoe during
More informationOvarian stimulation and inflammation, not always friends! Marc-André Sirard DVM PhD, Canadian Research Chair in Reproduction Genomics
Ovarian stimulation and inflammation, not always friends! Marc-André Sirard DVM PhD, Canadian Research Chair in Reproduction Genomics Conflict of interest Controlled Ovarian Stimulation Timing Test (COST2)GFI
More informationNew York Science Journal 2014;7(4)
The Minimal Stimulation Protocol for ICSI: An Alternative Protocol for Ovarian Stimulation Adel Elsayed Ibrahim, MD Assisted Reproductive Unit Azhar University Adel.sayed29@gmail.com Abstract: Background:
More informationZsolt P.Nagy 1, Cecile Janssenswillen, Ronny Janssens, Anick De Vos, Cathérine Staessen, Hilde Van de Velde and André C.
Human Reproduction vol.13 no.6 pp.1606 1612, 1998 Timing of oocyte activation, pronucleus formation and cleavage in humans after intracytoplasmic sperm injection (ICSI) with testicular spermatozoa and
More informationOocyte maturation. A.Trounson 1 ' 3, C.Anderiesz 1, G.MJones 1, A.Kausche 1, N.Lolatgis 2 and C.Wood 2
A.Trounson 1 ' 3, C.Anderiesz 1, G.MJones 1, A.Kausche 1, N.Lolatgis 2 and C.Wood 2 Centre for Early Human Development, Institute of Reproduction and Development, Monash University, Monash Medical Centre,
More informationModule 3. Infertility: Protocols and Patient Management
Module 3 Infertility: Protocols and Patient Management Ann Scalia, BSN, RN, CNOR Manager Clinical Education Specialists Mary Vietzke, BSN, RN Senior Clinical Educational Specialist Walgreens Faculty Ann
More informationFemale Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF
Female Reproductive Physiology Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF REFERENCE Lew, R, Natural History of ovarian function including assessment of ovarian reserve
More informationDrug Therapy Guidelines
Drug Therapy Guidelines Applicable Injectable Fertility Medications: Bravelle, Cetrotide, Follistim AQ, Ganirelix, Gonal-F, human chorionic gonadotropin, leuprolide, Menopur, Novarel, Ovidrel, Pregnyl,
More informationComparison of Two Embryo Scoring Systems for Prediction of Outcome in Assisted Reproductive Techniques Cycles
ORIGINAL ARTICLE Comparison of Two Embryo Scoring Systems for Prediction of Outcome in Assisted Reproductive Techniques Cycles Farnaz Sohrabvand 1, Mamak Shariat 2, Navid Fotoohi Ghiam 3, and Mahdi Hashemi
More informationOvarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase
Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase Michael von Wolff, M.D., a Christian J. Thaler, M.D., b Torsten Frambach, M.D., c Cosima Zeeb,
More informationDrug Therapy Guidelines
Drug Therapy Guidelines Applicable Medical Benefit Effective: 8/15/18 Pharmacy- Formulary 1 x Next Review: 6/18 Pharmacy- Formulary 2 x Date of Origin: 7/00 Injectable Fertility Medications: Bravelle,
More informationPremature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles
Arch Gynecol Obstet (2010) 281:747 752 DOI 10.1007/s00404-009-1248-0 REPRODUCTIVE MEDICINE Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles Esra
More informationComparison of development and implantation of human embryos biopsied with two different methods: aspiration and displacement
Comparison of development and implantation of human embryos biopsied with two different methods: aspiration and displacement Wei-Hua Wang, Ph.D., Khalied Kaskar, M.S., Yuhong Ren, M.S., Jimmy Gill, M.D.,
More informationEmbryo Selection after IVF
Embryo Selection after IVF Embryo Selection after IVF Many of human embryos produced after in vitro fertilization carry abnormal chromosomes. Placing a chromosomally normal embryo (s) into a normal uterus
More informationShould we advise patients undergoing IVF to start a cycle leading to a day 3 or a day 5 transfer?
Human Reproduction Vol.19, No.11 pp. 2550 2554, 2004 Advance Access publication August 6, 2004 doi:10.1093/humrep/deh447 Should we advise patients undergoing IVF to start a cycle leading to a day 3 or
More informationFollicular fluid steroid hormone levels are associated with fertilization outcome after intracytoplasmic sperm injection
Follicular fluid steroid hormone levels are associated with fertilization outcome after intracytoplasmic sperm injection Julie D. Lamb, M.D., a A. Musa Zamah, M.D., Ph.D., a Shehua Shen, M.D., a Charles
More informationAssisted Reproduction. Rajeevi Madankumar, 1,2 James Tsang, 1 Martin L. Lesser, 1 Daniel Kenigsberg, 1 and Steven Brenner 1 INTRODUCTION
( C 2005) DOI: 10.1007/s10815-005-4912-8 Assisted Reproduction Clomiphene citrate induced ovulation and intrauterine insemination: effect of timing of human chorionic gonadotropin injection in relation
More informationAgonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M
Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M Record Status This is a critical abstract of an economic
More information